Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions

SARS-CoV2 Infection Common PathogensDiabetes Mellitus, Type 1

Interventions

PROCEDURE

venous blood sample

Phlebotomy procedure for a venous blood draw.

Trial Locations (1)

Cwm Taf Morgannwg University Health board, Llantrisant

All Listed Sponsors

collaborator

Cardiff University

OTHER

collaborator

University of Oxford

OTHER

collaborator

Imperial College London

OTHER

lead

Cwm Taf University Health Board (NHS)

OTHER_GOV

NCT05171998 - Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes | Biotech Hunter | Biotech Hunter